Insider Transactions in Q4 2022 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,268
-0.3%
|
$6,804
$3.1 P/Share
|
|
Dec 31
2022
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,497
-0.27%
|
$7,491
$3.1 P/Share
|
|
Dec 31
2022
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,996
-2.45%
|
$11,988
$3.1 P/Share
|
|
Dec 31
2022
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,025
-5.87%
|
$132,075
$3.1 P/Share
|
|
Dec 31
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,921
-2.08%
|
$8,763
$3.1 P/Share
|
|
Dec 31
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,303
-2.21%
|
$15,909
$3.1 P/Share
|
|
Dec 31
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
3,014
-2.15%
|
$9,042
$3.1 P/Share
|
|
Dec 31
2022
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,889
-2.12%
|
$14,667
$3.1 P/Share
|
|
Dec 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,400
-1.22%
|
$28,200
$3.91 P/Share
|
|
Nov 01
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
9,700
-1.25%
|
$38,800
$4.03 P/Share
|
|
Oct 03
2022
|
Thomas Templeman Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,455
-1.78%
|
$7,365
$3.95 P/Share
|
|
Oct 03
2022
|
David J Grainger Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
2,853
-0.31%
|
$8,559
$3.95 P/Share
|
|
Oct 03
2022
|
Gregory M Weinhoff Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,901
-2.08%
|
$14,703
$3.95 P/Share
|
|
Oct 03
2022
|
Antoine Yver EVP & Chairman of Development |
SELL
Open market or private sale
|
Direct |
12,524
-1.59%
|
$37,572
$3.92 P/Share
|
|
Oct 03
2022
|
Iqbal J Hussain General Counsel |
SELL
Open market or private sale
|
Direct |
4,563
-2.86%
|
$13,689
$3.95 P/Share
|
|
Oct 03
2022
|
Javad Shahidi Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,341
-2.06%
|
$10,023
$3.95 P/Share
|
|
Oct 03
2022
|
David M Chao Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
4,167
-1.83%
|
$12,501
$3.95 P/Share
|
|
Oct 03
2022
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Open market or private sale
|
Direct |
2,595
-1.88%
|
$7,785
$3.95 P/Share
|